+143.3%
MRNA vs NTAP
+87.9%
+55.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | NTAP | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -2.3% | -1.0% | -4.9% |
| 7D | -10.1% | +2.2% | -12.3% | -8.7% |
| 30D | +126.7% | -7.0% | +133.8% | +115.7% |
| 3M | +184.1% | +12.3% | +171.8% | +165.9% |
| 6M | +143.3% | +85.1% | +58.2% | +96.8% |
| All | +143.3% | +87.9% | +55.4% | +96.8% |
Cumulative growth
Daily Returns
Daily percentage return beside NTAP.
Daily Out/Under-Performance
Portfolio return minus NTAP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NTAP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded NTAP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling